about
Advances in kilovoltage x-ray beam dosimetryUnraveling Kinase Activation Dynamics Using Kinase-Substrate Relationships from Temporal Large-Scale Phosphoproteomics Studies.ORTI: An Open-Access Repository of Transcriptional Interactions for Interrogating Mammalian Gene Expression Data.Simulation of real-time EPID images during IMRT using Monte-Carlo.A generalised enzyme kinetic model for predicting the behaviour of complex biochemical systemsMolecular Dynamics Simulations of Insulin: Elucidating the Conformational Changes that Enable Its BindingIn silico nanodosimetry: new insights into nontargeted biological responses to radiationElucidating the Activation Mechanism of the Insulin-Family Proteins with Molecular Dynamics Simulations.Image quality in thoracic 4D cone-beam CT: a sensitivity analysis of respiratory signal, binning method, reconstruction algorithm, and projection angular spacing.Impact of fluorescence emission from gold atoms on surrounding biological tissue-implications for nanoparticle radio-enhancement.Markerless tumor tracking using short kilovoltage imaging arcs for lung image-guided radiotherapy.The feasibility of head motion tracking in helical CT: a step toward motion correction.Correction for human head motion in helical x-ray CT.Improving thoracic four-dimensional cone-beam CT reconstruction with anatomical-adaptive image regularization (AAIR).A rigid motion correction method for helical computed tomography (CT).Dose enhancement effects to the nucleus and mitochondria from gold nanoparticles in the cytosol.Issues involved in the quantitative 3D imaging of proton doses using optical CT and chemical dosimetersComputational study of the activity, dynamics, energetics and conformations of insulin analogues using molecular dynamics simulations: Application to hyperinsulinemia and the critical residue B26.Unraveling the mechanistic complexity of Alzheimer's disease through systems biology.Estimation of effective imaging dose for kilovoltage intratreatment monitoring of the prostate position during cancer radiotherapy.Correction: Unraveling Kinase Activation Dynamics Using Kinase-Substrate Relationships from Temporal Large-Scale Phosphoproteomics StudiesCharacterization of optical transport effects on EPID dosimetry using Geant4.EPID dosimetry: effect of different layers of materials on absorbed dose response.Radiation damage on sub-cellular scales: beyond DNA.A system for EPID-based real-time treatment delivery verification during dynamic IMRT treatment.Characterization of a novel EPID designed for simultaneous imaging and dose verification in radiotherapy.The transcriptional response to oxidative stress is part of, but not sufficient for, insulin resistance in adipocytes.Toward Personalized Dosimetry with 32P Microparticle Therapy for Advanced Pancreatic Cancer.In silico investigation of factors affecting the MV imaging performance of a novel water-equivalent EPID.Towards optimal imaging with PET: an in silico feasibility study.Nanoparticle radio-enhancement: principles, progress and application to cancer treatment.SU-E-I-109: Sensitivity Analysis of an Electronic Portal Imaging Device Monte Carlo Model to Variations in Optical Transport Parameters.Polarisation-based coincidence event discrimination: an in silico study towards a feasible scheme for Compton-PET.An evaluation of calculation parameters in the EGSnrc/BEAMnrc Monte Carlo codes and their effect on surface dose calculation.Predicted ionisation in mitochondria and observed acute changes in the mitochondrial transcriptome after gamma irradiation: a Monte Carlo simulation and quantitative PCR study.A data-driven, knowledge-based approach to biomarker discovery: application to circulating microRNA markers of colorectal cancer prognosis.A study of surface dosimetry for breast cancer radiotherapy treatments using Gafchromic EBT2 film.Multiband study of NGC 7424 and its two newly discovered ultraluminous X-ray sourcesThe quenching effect in PRESAGE® dosimetry of proton beams: Is an empirical correction feasible?Radiation treatment dose optimisation using Poisson tumour control probability parameters
P50
Q22242961-E119B5BF-4EB2-46EA-B5E6-740E3B757CE9Q30489492-55FC50CF-1299-46D1-B928-F69EC6E9C030Q30490157-53191D39-D757-45EF-A737-B7047F99D7A7Q35029635-B72FCA50-44BD-4008-B56A-545013C33E0DQ35251533-BF5B1E8E-2653-42BD-A90F-7E68163568C1Q35858451-A6496E48-2437-4302-BDBC-0D9A584C8C21Q36021668-1F430C1E-60D9-4AC1-B74A-D9E82239084DQ36109196-ADFF4C2B-5321-4F0A-9E69-AC57D110ED05Q38643605-EB2C3EE9-5B64-4C90-A038-14AFBBE30637Q38754555-D363706C-2ADB-46E5-8D21-56C432FC6483Q38941164-AF4B83CB-5166-47DB-8ABF-33984F469BDDQ39440122-92539517-5ECC-4F88-AD36-2C40F35ECB32Q40064906-807C5F8D-6066-465F-853D-48E753FF8216Q40247818-41FBF0D2-64A4-4D4B-B3F9-4B66FFD48285Q41445819-8339309A-9E5A-4913-B043-B4EB7D3F9699Q41468679-D193A24D-AF70-42FC-A0B8-9440DA14439CQ41631245-4986976A-EA72-4B2F-8E67-1D61FE675815Q41682209-94CF7D7D-B99A-4E92-AC52-E33E4BBA151DQ42126776-8616AE57-7A73-4F40-9848-F4BA10F475A6Q42315452-05420C55-4829-43E1-AA25-9F2259DA9C62Q42366306-3755E989-6841-42DD-A11D-368667AD26BDQ42694977-D7CC2720-D92D-4C46-B015-6B06A280CADBQ43186139-E5B77EBD-2BD2-45DA-BAA9-6E91ED4FD66CQ44029655-E5A8E18F-FD57-4AE0-A6FE-D8D650599491Q45080493-A5BF37F7-33ED-49A7-9094-71C6CD4298DAQ45155261-444A59AE-A446-430D-AB18-9D0914AACE20Q47555200-6165C75D-FD91-4023-9762-BD69CBC17A59Q47731805-91FE6E79-3B93-4890-A853-4850774B2456Q48477420-B06D6F9B-8BDA-4C3B-B7B7-9096D15CAE1EQ48807595-AB7D5605-2000-4385-B12F-936862C96B48Q50070213-680364BC-C398-4076-A29A-614E31E0D576Q50940894-6B7F5502-6644-4B6D-B711-62701897161DQ51251723-C061234C-495D-4AD8-A378-1CA4CA8A443AQ51348527-7B3A140B-4DF0-43DE-BDE8-F6070E1577B2Q54268680-7E9FADB3-4F61-4DA7-B60D-A05DE136A94CQ55166178-84314A37-0F5C-40E3-B803-ED9C7C902E75Q55349633-1725142A-AFB5-4283-8531-4B111E83416CQ56048750-4D96F882-F2A6-40EC-8E87-6F9FEDE74E9BQ56740091-ED02C30A-E1B1-4F47-9174-4B65EFFAD9DEQ56740159-90F88D1A-EE88-46FB-B915-0EB23485FCE8
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Zdenka Kuncic
@ast
Zdenka Kuncic
@en
Zdenka Kuncic
@es
Zdenka Kuncic
@nl
Zdenka Kuncic
@sl
type
label
Zdenka Kuncic
@ast
Zdenka Kuncic
@en
Zdenka Kuncic
@es
Zdenka Kuncic
@nl
Zdenka Kuncic
@sl
prefLabel
Zdenka Kuncic
@ast
Zdenka Kuncic
@en
Zdenka Kuncic
@es
Zdenka Kuncic
@nl
Zdenka Kuncic
@sl
P106
P1153
6603098070
P21
P31
P496
0000-0001-6765-3215